Equity Overview
Price & Market Data
Price: $19.21
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $584,882,368
Daily Volume: 0
Performance Metrics
1 Week: 15.58%
1 Month: 59.15%
3 Months: 72.91%
6 Months: 63.91%
1 Year: 8.96%
YTD: 61.97%
Company Details
Employees: 44
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.